Helixate NexGen
Active substance: antihemophilic factor, human recombinant
octocog alfa
Centralised EU authorisationWithdrawn
Marketing holder: Bayer AG
Verified 2026-10-09 · EMA
- Source: EMA
- Countries with the substance registered: 1
Composition
Registration
- Registration number
- EMEA/H/C/000276
- Registration status
- Withdrawn
- ATC code
- B02BD02
Sources
- product · EMA · EMEA/H/C/000276 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/000276 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/000276 · Verified 2026-10-09